Clinical trial
COREG MR Versus TOPROL-XL On The Lipid Profile Of Normolipidemic Or Mildly…
NCT00273052 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00273052 |
|---|---|
| Title | COREG MR Versus TOPROL-XL On The Lipid Profile Of Normolipidemic Or Mildly Dyslipidemic Patients With Hypertension |
| Official title | A Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Carvedilol Phosphate Modified Release Formulation (COREG- MR) With Metoprolol Succinate (TOPROL XL) on the Lipid Profile in Normolipidemic, or Mildly Dyslipidemic Hypertensive Patients |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | Carvedilol Phosphate modified release formulation, metoprolol succinate |
| Enrollment | 514 |
| Start date | Jan 5, 2006 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 28, 2007 |
| First posted | Jan 9, 2006 |
| Last update posted | Jun 25, 2018 |
| Countries | Canada, Puerto Rico, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: